Insider trading

Period: 120 months Stock: OLMA Role: Other officers × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

48 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

48 decisions over 120 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

48 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

48 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
48 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
48 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

48 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
4 Mar 2026
Mitchell Shawnte CHIEF LEGAL OFFICER
Sold at will 2×
$606.35K 25,000 at 24.25
100%
Sold half or more
3 Mar 2026
Mitchell Shawnte CHIEF LEGAL OFFICER
Sold at will
$345.15K 15,000 at 23.01
100%
Sold half or more
15 Jan 2026
Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF.
Sold at will
$2.87M 100,000 at 28.73
41.7%
Not planned
14 Jan 2026
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF
Sold at will 2×
$1.44M 50,000 at 28.87
8.4%
Not planned
13 Jan 2026
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF
Sold at will 2×
$1.38M 50,000 at 27.60
8.4%
Not planned
13 Jan 2026
Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF.
Sold at will
$107.05K 3,822 at 28.01
1.6%
Not planned
12 Jan 2026
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF · indirect
Sold at will
$283.40K 10,000 at 28.34
6.5%
Not planned
23 Dec 2025
Zojwalla Naseem Chief Medical Officer
Sold at will
$2.75M 99,509 at 27.66
95.7%
Sold half or more
22 Dec 2025
Zojwalla Naseem Chief Medical Officer
Sold at will
$2.80M 100,000 at 28.04
64.9%
Sold half or more
19 Dec 2025
Zojwalla Naseem Chief Medical Officer
Sold at will 2×
$1.97M 70,000 at 28.20
40.2%
Not planned
19 Dec 2025
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF
Sold at will 3×
$1.55M 51,000 at 30.46
8.5%
Not planned
11 Dec 2024
Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF.
Sold at will 2×
$159.26K 18,356 at 8.68
3.3%
Not planned
11 Dec 2024
Zojwalla Naseem CHIEF MEDICAL OFFICER
Sold at will 2×
$125.99K 14,522 at 8.68
11.2%
Not planned
11 Dec 2024
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF
Sold at will 2×
$118.12K 13,614 at 8.68
2.2%
Not planned
10 Dec 2024
Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF.
Sold at will
$157.44K 16,803 at 9.37
2.9%
Not planned
10 Dec 2024
Zojwalla Naseem CHIEF MEDICAL OFFICER
Sold at will
$124.46K 13,283 at 9.37
9.3%
Not planned
10 Dec 2024
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF
Sold at will
$116.80K 12,452 at 9.38
2.0%
Not planned
22 Nov 2023
Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF.
Sold at will
$127.02K 9,145 at 13.89
2.1%
Not planned
22 Nov 2023
Zojwalla Naseem CHIEF MEDICAL OFFICER
Sold at will
$98.55K 7,095 at 13.89
18.8%
Not planned
22 Nov 2023
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF
Sold at will
$92.41K 6,653 at 13.89
1.1%
Not planned
21 Nov 2023
Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF.
Sold at will 2×
$142.63K 9,597 at 14.86
2.2%
Not planned
21 Nov 2023
Zojwalla Naseem CHIEF MEDICAL OFFICER
Sold at will 2×
$110.75K 7,461 at 14.84
16.5%
Not planned
21 Nov 2023
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF
Sold at will 2×
$103.82K 6,976 at 14.88
1.2%
Not planned
8 Nov 2023
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF
Sold on a plan
$3.52K 200 at 17.61
0.0%
Planned (10b5-1)
3 Nov 2023
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF
Sold on a plan
$9.47K 541 at 17.51
0.1%
Planned (10b5-1)
2 Nov 2023
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF
Sold on a plan
$51.18K 3,332 at 15.36
0.6%
Planned (10b5-1)
1 Nov 2023
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF
Sold on a plan
$100.15K 6,668 at 15.02
1.2%
Planned (10b5-1)
19 Sep 2023
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF
Sold on a plan
$253.40K 20,000 at 12.67
3.4%
Planned (10b5-1)
6 Apr 2023
Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF.
Bought
no price 10,000 shares
2.6%
2 Sep 2022
Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF.
Bought
no price 20,000 shares
5.5%
First buy on file
10 Mar 2022
Horn Kinney CHIEF BUSINESS OFFICER
Sold, plan not stated
$24.95K 5,253 at 4.75
68.1%
Sold half or more
10 Jan 2022
Horn Kinney CHIEF BUSINESS OFFICER
Sold, plan not stated
$35.97K 5,251 at 6.85
68.1%
Sold half or more
10 Dec 2021
Myles David C. CHIEF DEVELOPMENT OFFICER
Sold, plan not stated
$103.00K 10,000 at 10.30
1.7%
10 Dec 2021
Horn Kinney CHIEF BUSINESS OFFICER
Sold, plan not stated
$54.56K 5,251 at 10.39
68.1%
Sold half or more
29 Nov 2021
Harmon Cyrus CHIEF TECHNOLOGY OFFICER
Sold, plan not stated
$9.90K 400 at 24.76
0.0%
10 Nov 2021
Horn Kinney CHIEF BUSINESS OFFICER
Sold, plan not stated
$743.72K 27,668 at 26.88
93.9%
Sold half or more
19 Oct 2021
Harmon Cyrus CHIEF TECHNOLOGY OFFICER
Sold, plan not stated 2×
$335.79K 12,000 at 27.98
1.1%
11 Oct 2021
Horn Kinney CHIEF BUSINESS OFFICER
Sold, plan not stated 2×
$146.51K 5,251 at 27.90
74.6%
Sold half or more
20 Sep 2021
Harmon Cyrus CHIEF TECHNOLOGY OFFICER
Sold, plan not stated
$315.60K 12,000 at 26.30
1.1%
10 Sep 2021
Horn Kinney CHIEF BUSINESS OFFICER
Sold, plan not stated
$154.27K 5,251 at 29.38
74.6%
Sold half or more
19 Aug 2021
Harmon Cyrus CHIEF TECHNOLOGY OFFICER
Sold, plan not stated
$299.64K 12,000 at 24.97
1.1%
10 Aug 2021
Horn Kinney CHIEF BUSINESS OFFICER
Sold, plan not stated 2×
$134.98K 5,251 at 25.71
74.6%
Sold half or more
20 Jul 2021
Harmon Cyrus CHIEF TECHNOLOGY OFFICER
Sold, plan not stated
$105.67K 4,123 at 25.63
0.4%
19 Jul 2021
Harmon Cyrus CHIEF TECHNOLOGY OFFICER
Sold, plan not stated
$195.59K 7,877 at 24.83
0.7%
12 Jul 2021
Horn Kinney CHIEF BUSINESS OFFICER
Sold, plan not stated 2×
$139.19K 5,251 at 26.51
74.6%
Sold half or more
18 Jun 2021
Harmon Cyrus CHIEF TECHNOLOGY OFFICER
Sold, plan not stated 3×
$297.63K 12,000 at 24.80
1.1%
10 Jun 2021
Horn Kinney CHIEF BUSINESS OFFICER
Sold, plan not stated 3×
$156.07K 5,251 at 29.72
74.6%
Sold half or more
18 May 2021
Horn Kinney CHIEF BUSINESS OFFICER
Sold, plan not stated 2×
$1.39M 57,763 at 24.15
97.0%
Sold half or more
Showing 1–48 of 48.